Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Russia

- PMLiVE

CureVac reveals early data for mRNA-based COVID-19 vaccine candidate

German biotech says vaccine demonstrated an immune response in phase 1/2

- PMLiVE

Regeneron halts enrolment of severely ill patients in COVID-19 antibody trial

Trial modified based on recommendations from independent data monitoring committee

Article

How will COVID-19 affect uptake of vaccinations against other diseases?

Research Partnership

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.

Impetus Digital

Webcast

China: How pharma can maximize success in this rapidly changing emerging market

Research Partnership

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma...

Impetus Digital

Solving the Caregiver Crisis Through Technology

Curtis Khan, CEO and Founder of BookJane, discusses the ongoing caregiver crisis and how BookJane’s solutions and other digital technologies can help to close this gap. We also delve into how...

Impetus Digital

Therapeutic VR for Managing Pain & Improving Patient Outcomes

Ramsay Brown, CEO and Founder of Quol, delves into several different HealthTech topics, including the concept of VR therapeutics and the importance of incorporating behavioral science and neuroscience into VR solutions, as...

Impetus Digital

- PMLiVE

The impact of COVID-19 on cancer care

The COVID-19 pandemic has bought great challenges to healthcare systems globally. A World Health Organization (WHO) survey of 155 countries in the height of the pandemic reported disrupted services worldwide, ranging from...

Porterhouse Medical Group

- PMLiVE

UK’s MHRA begins rolling review of Moderna’s coronavirus vaccine

MHRA will accept and consider new evidence as it becomes available

- PMLiVE

Russia submits COVID-19 vaccine to WHO for emergency use listing

Russia became first country to grant approval to a COVID-19 vaccine in August

- PMLiVE

UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’

Taskforce has so far secured access to six potential COVID-19 vaccines

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links